Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.0005 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.15 | 0.004 |